A Phase 3 interventional study of dosage of the NFS and iron in Anemia, sponsored by University Hospital, Limoges. Completed at 1 site in France. Open to female participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2016-08-22.
Sponsored by University Hospital, Limoges · Phase 3, Interventional, and Diagnostic
Estimate the efficiency of a strategy of premature screening of the maternal anaemia during the first quarter of pregnancy versus the usual strategy of screening of the anaemia during the sixth month.
A part of the patient will have a NFS and dosage of the cast-iron, during the results of the beginning of the pregnancy at the first quarter.
The other part of the patients will have a NFS and at the first quater of the pregnancy.
All the patient will have a NFS at the results of the sixth month of the pregnancy.
A NFS will be done during the results at the end of the pregnancy like we do now.
Then a NFS at 48 hours after the birth. A treatment with iron will be done and according to the results
1,733 studies on the registry are indexed under Anemia; 246 are open to participants now.
This study's enrollment of 80 is below the median of 94 across 1,291 interventional studies indexed under Anemia.
Browse Anemia studies →University Hospital, Limoges is the lead sponsor of 255 studies on the registry; 36 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
first arm: dosage NFS and iron during the beginning of the pregnancy then in the sixth month of pregnancy then in th delivery.
Biological: dosage of the NFS and iron
second arm: dosage NFS and iron during the sixth month of pregnancy then in th delivery. No dosage of NFS and iron during the beginning of the pregnancy
Biological: dosage of the NFS and iron
a blood test will be made.
primary outcomes: is the rate of heamophilia at the end of the pregnancy.
Time frame: six months
Secondary outcomes: - the percent of treatment of intravenous irons during the pregnancy and the following layers. - the percent of transfusion and the following layers.
Time frame: 6 months
This study is completed, as verified in Sep 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Limoges